| Name | (2-ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone |
|---|---|
| Synonyms |
Benzaron
2-ETHYL-3-(4-HYDROXYBENZOYL)BENZOFURAN (2-Ethyl-1-benzofuran-3-yl)-(4-hydroxyphenyl)methanone (2-Ethylbenzofuran-3-yl)(4-hydroxyp Benzbromone Impurity C Benzone (B0490000) Inhibitor,URAT1,uric acid,inhibit,SLC22A12,Urate transporter 1,Benzone,Fragivix,hURAT1 2-Ethyl-3-benzofuranyl-p-hydroxyphenyl ketone (2-Ethyl-3-benzofuranyl)(4-hydroxyphenyl)methanone Fragivix Fragivil (2-ethylbenzofuran-3-yl)-(4-hydroxyphenyl)methanone (2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone (Benzone) Benzone, 10 mM in DMSO Methanone, (2-ethyl-3-benzofuranyl)(4-hydroxyphenyl) Benzonum Venagil Benzona 2-Ethyl-3-p-hydroxybenzoylbenzofuran Fagivil Benzon Benzone (2-ETHYL-1-BENZOFURAN-3-YL)(4-HYDROXYPHENYL)METHANONE Benzone CRS Vasoc Benzbromone Impurity C (Benzone) Benzbromone Impurity 3(Benzbromone Impurity C) (2-Ethylbenzofuran-3-yl)(4-hydroxyphenyl)methanone 2-Ethylbenzofuran-3-yl 4-hydroxyphenyl ketone |
| Description | Benzarone (Fragivix) is a potent human uric acid transporter 1 (hURAT1) inhibitor, with an IC50 of 2.8 μM in oocyte. Benzarone could lower uric acid serum levels[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 2.8 μM (hURAT1 in oocyte)[1] |
| References |
| Density | 1.234g/cm3 |
|---|---|
| Boiling Point | 473.6ºC at 760mmHg |
| Melting Point | 124.3° |
| Molecular Formula | C17H14O3 |
| Molecular Weight | 266.29100 |
| Flash Point | 240.2ºC |
| Exact Mass | 266.09400 |
| PSA | 50.44000 |
| LogP | 3.93180 |
| Vapour Pressure | 1.36E-09mmHg at 25°C |
| Index of Refraction | 1.638 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| HS Code | 2932999099 |
|---|
|
~90%
1477-19-6 |
| Literature: J-PHARMA CO., LTD.; WEMPE, Michael, F.; ENDOU, Hitoshi Patent: WO2012/48058 A2, 2012 ; Location in patent: Page/Page column 14-15 ; WO 2012/048058 A2 |
|
~%
1477-19-6 |
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 |
|
~%
1477-19-6 |
| Literature: Journal of the Chemical Society, , p. 625,627 |
|
~%
1477-19-6 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 8 p. 2701 - 2713 |
|
~%
1477-19-6 |
| Literature: Journal of Medicinal Chemistry, , vol. 54, # 8 p. 2701 - 2713 |
|
~%
1477-19-6 |
| Literature: WO2012/48058 A2, ; WO 2012/048058 A2 |
|
~%
1477-19-6 |
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 |
|
~%
1477-19-6 |
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 |
|
~%
1477-19-6 |
| Literature: Bulletin de la Societe Chimique de France, , p. 1682,1685 |
| HS Code | 2932999099 |
|---|---|
| Summary | 2932999099. other heterocyclic compounds with oxygen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |